Cargando…
Pediatric Ulcerative Colitis: The Therapeutic Road to Infliximab
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that has significant morbidities in the pediatric population. Goals of medical therapy include induction and maintenance of remission while preserving the colon and it’s function, while minimizing the risk of treatment related morbiditi...
Autores principales: | Puthoor, Pamela R., de Zoeten, Edwin F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873070/ https://www.ncbi.nlm.nih.gov/pubmed/24392300 http://dx.doi.org/10.1007/s13554-012-0006-1 |
Ejemplares similares
-
Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008) -
Therapeutic Drug Monitoring of Infliximab in Acute Severe Ulcerative Colitis
por: Gordon, Benjamin L., et al.
Publicado: (2023) -
Early Serum Infliximab Levels in Pediatric Ulcerative Colitis
por: deBruyn, Jennifer C. C., et al.
Publicado: (2021) -
Pediatric ulcerative colitis: current treatment approaches including role of infliximab
por: Bradley, Gia M, et al.
Publicado: (2012) -
Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update
por: Lawlor, Garrett, et al.
Publicado: (2009)